Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(33.3%)
Phase 1
1(33.3%)
N/A
1(33.3%)
3Total
Phase 2(1)
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03384706Not ApplicableCompleted

A Comparison of CPT Versus ART Versus WL

Role: collaborator

NCT00033033Phase 2Completed

Reserpine for the Treatment of Cocaine Dependence - 1

Role: collaborator

NCT00033098Phase 1Unknown

Cocaine-Metyrapone Interaction Study - 1

Role: collaborator

NCT01709448Unknown

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV

Role: collaborator

All 4 trials loaded